user

Antibody treatment for ovarian cancer

被引：0
|
作者：
Liddle, Rachel
机构：
来源：
LANCET ONCOLOGY | 2007年 / 8卷 / 08期
关键词：
D O I：
10.1016/S1470-2045(07)70229-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：676 / 676
页数：1
相关论文
共 50 条
  • [1] Antibody-drug conjugates for the treatment of ovarian cancer
    Calo, Corinne A.
    O'Malley, David M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (07) : 875 - 887
  • [2] Antibody Drug Conjugates in the Treatment of Epithelial Ovarian Cancer
    Richardson, Debra L.
    Seward, Shelly M.
    Moore, Kathleen N.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2018, 32 (06) : 1057 - +
  • [3] AN ANTI-AMPHIREGULIN ANTIBODY AS POTENTIAL TREATMENT FOR OVARIAN CANCER
    Zmora, Einav
    Lindzen, Moshit
    Yarden, Yosef
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 232 - 232
  • [4] Antibody therapy in ovarian cancer
    Kimmig, R
    Wimberger, P
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2005, 55 (11): : 711 - 712
  • [5] Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer
    Sato, Sho
    Shoji, Tadahiro
    Jo, Ami
    Otsuka, Haruka
    Abe, Marina
    Tatsuki, Shunsuke
    Chiba, Yohei
    Takatori, Eriko
    Kaido, Yoshitaka
    Nagasawa, Takayuki
    Kagabu, Masahiro
    Baba, Tsukasa
    CANCERS, 2024, 16 (14)
  • [6] Treatment of drug resistant ovarian cancer cells with daunorubicin antibody conjugates
    Page, B
    Page, M
    MOLECULAR BIOLOGY OF THE CELL, 1996, 7 : 447 - 447
  • [7] Treatment with an uPAR (ATN 658) antibody inhibits ovarian cancer metastasis.
    Kenny, Hilary A.
    Jagadeeswaran, Sujatha
    Mazar, Andrew P.
    Lengyel, Ernst
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3536S - 3536S
  • [8] Interdisciplinary management of treatment with antibody-drug conjugates in recurrent ovarian cancer
    Lueftner, Diana
    Stahlhut, Kerstin
    Untch, Michael
    Konecny, Gottfried
    ONKOLOGIE, 2025,
  • [9] Targetable HPMA copolymer-drug-antibody conjugates for the treatment of ovarian cancer
    J Control Release, 2-3 (292):
  • [10] Genomic discovery and validation of a therapeutic antibody target for ovarian cancer treatment.
    Papkoff, J
    Tobler, A
    Ghosh, MV
    Kmet, M
    Tang, T
    Terwey, D
    Miller, P
    Li, W
    Tringler, B
    Shroyer, K
    Pilkington, G
    Lindsay, R
    Macina, RE
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6122S - 6122S
12345